Literature DB >> 21200021

HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells.

David Favre1, Cheryl A Stoddart, Brinda Emu, Rebecca Hoh, Jeffrey N Martin, Frederick M Hecht, Steven G Deeks, Joseph M McCune.   

Abstract

HIV infection can result in depletion of total CD4(+) T cells and naive CD8(+) T cells, and in the generation of dysfunctional effector CD8(+) T cells. In this study, we show that naive CD8(+) T cells in subjects with progressive HIV disease express low levels of CD8α and CD8β chains. Such naive CD8(low) T cells display broad signaling defects across the T-cell receptor complex, and their appearance correlates with generalized up-regulation of major histocompatibility complex class I (MHC-I) antigens on peripheral blood mononuclear cells (PBMCs). To explore a causal link between increased MHC-I up-regulation and the generation of naive CD8(low) T cells, we used the humanized SCID-hu Thy/Liv mouse model to show that HIV infection of the thymus and interferon α (IFNα) treatment alone result in MHC-I up-regulation and in the generation of dysfunctional CD3(high)CD8(+)CD4(-) single-positive 8 (SP8) thymocytes with low expression of CD8. We suggest that dysfunctional naive CD8(low) T cells are generated as a result of IFNα-mediated up-regulation of MHC-I on stromal cells in the thymus and antigen-presenting cells in the periphery, and that dysfunction in this naive compartment contributes to the immunodeficiency of HIV disease. This study is registered at www.clinicaltrials.gov as NCT00187512.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21200021      PMCID: PMC3062328          DOI: 10.1182/blood-2010-06-288035

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

Review 1.  The dynamics of T cell receptor signaling: complex orchestration and the key roles of tempo and cooperation.

Authors:  R N Germain; I Stefanová
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

2.  Selection and long-term persistence of reactive CTL clones during an EBV chronic response are determined by avidity, CD8 variable contribution compensating for differences in TCR affinities.

Authors:  C Couedel; M Bodinier; M A Peyrat; M Bonneville; F Davodeau; F Lang
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

3.  Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.

Authors:  David M Asmuth; Robert L Murphy; Susan L Rosenkranz; Juan J L Lertora; Shyam Kottilil; Yoninah Cramer; Ellen S Chan; Robert T Schooley; Charles R Rinaldo; Nathan Thielman; Xiao-Dong Li; Sharon M Wahl; Jessica Shore; Jennifer Janik; Richard A Lempicki; Yaa Simpson; Richard B Pollard
Journal:  J Infect Dis       Date:  2010-06-01       Impact factor: 5.226

Review 4.  Type I interferons in systemic autoimmunity.

Authors:  Silvano Sozzani; Daniela Bosisio; Mirko Scarsi; Angela Tincani
Journal:  Autoimmunity       Date:  2010-04       Impact factor: 2.815

5.  Chronic modulation of the TCR repertoire in the lymphoid periphery.

Authors:  C A Blish; B J Gallay; G L Turk; K M Kline; W Wheat; P J Fink
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

6.  Anergic CD8+ T cells can persist and function in vivo.

Authors:  C A Blish; S R Dillon; A G Farr; P J Fink
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

7.  Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo.

Authors:  Robert Maile; Catherine A Siler; Samantha E Kerry; Katherine E Midkiff; Edward J Collins; Jeffrey A Frelinger
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

8.  Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

Authors:  J V Giorgi; L E Hultin; J A McKeating; T D Johnson; B Owens; L P Jacobson; R Shih; J Lewis; D J Wiley; J P Phair; S M Wolinsky; R Detels
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

9.  Expression of the CD8alpha beta-heterodimer on CD8(+) T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus- and human immunodeficiency virus+ individuals.

Authors:  J E Schmitz; M A Forman; M A Lifton; O Concepción; K A Reimann; C S Crumpacker; J F Daley; R S Gelman; N L Letvin
Journal:  Blood       Date:  1998-07-01       Impact factor: 22.113

10.  Viral immune evasion due to persistence of activated T cells without effector function.

Authors:  A J Zajac; J N Blattman; K Murali-Krishna; D J Sourdive; M Suresh; J D Altman; R Ahmed
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

View more
  14 in total

1.  Preconditioned mesenchymal stem cells treat myasthenia gravis in a humanized preclinical model.

Authors:  Muriel Sudres; Marie Maurer; Marieke Robinet; Jacky Bismuth; Frédérique Truffault; Diane Girard; Nadine Dragin; Mohamed Attia; Elie Fadel; Nicola Santelmo; Camille Sicsic; Talma Brenner; Sonia Berrih-Aknin
Journal:  JCI Insight       Date:  2017-04-06

2.  Combined HIV-1 sequence and integration site analysis informs viral dynamics and allows reconstruction of replicating viral ancestors.

Authors:  Sean C Patro; Leah D Brandt; Michael J Bale; Elias K Halvas; Kevin W Joseph; Wei Shao; Xiaolin Wu; Shuang Guo; Ben Murrell; Ann Wiegand; Jonathan Spindler; Castle Raley; Christopher Hautman; Michele Sobolewski; Christine M Fennessey; Wei-Shau Hu; Brian Luke; Jenna M Hasson; Aurelie Niyongabo; Adam A Capoferri; Brandon F Keele; Jeff Milush; Rebecca Hoh; Steven G Deeks; Frank Maldarelli; Stephen H Hughes; John M Coffin; Jason W Rausch; John W Mellors; Mary F Kearney
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-27       Impact factor: 11.205

3.  Alpha interferon and HIV infection cause activation of human T cells in NSG-BLT mice.

Authors:  Brian R Long; Cheryl A Stoddart
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

4.  LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patients.

Authors:  Akif Altinbas; Jacinta A Holmes; Shadi Salloum; Anna Lidofsky; Nadia Alatrakchi; Ma Somsouk; Peter Hunt; Steven Deeks; Kara W Chew; Georg Lauer; Annie Kruger; Wenyu Lin; Raymond T Chung
Journal:  Biomark Med       Date:  2022-07-05       Impact factor: 2.498

5.  Monocyte activation by interferon α is associated with failure to achieve a sustained virologic response after treatment for hepatitis C virus infection.

Authors:  Dennis J Hartigan-O'Connor; Din Lin; James C Ryan; Valentina A Shvachko; Myrna L Cozen; Mark R Segal; Norah A Terrault; Lewis L Lanier; M Michele Manos; Joseph M McCune
Journal:  J Infect Dis       Date:  2013-12-10       Impact factor: 5.226

Review 6.  Immunologic strategies for HIV-1 remission and eradication.

Authors:  Dan H Barouch; Steven G Deeks
Journal:  Science       Date:  2014-07-11       Impact factor: 47.728

7.  Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection.

Authors:  Anna Lidofsky; Jacinta A Holmes; Eoin R Feeney; Annie J Kruger; Shadi Salloum; Hui Zheng; Isabel S Seguin; Akif Altinbas; Ricard Masia; Kathleen E Corey; Jenna L Gustafson; Esperance A Schaefer; Peter W Hunt; Steven Deeks; Ma Somsouk; Kara W Chew; Raymond T Chung; Nadia Alatrakchi
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

8.  Expansion of Inefficient HIV-Specific CD8 T Cells during Acute Infection.

Authors:  Michael A Eller; Nilu Goonetilleke; Boonrat Tassaneetrithep; Leigh Anne Eller; Margaret C Costanzo; Susan Johnson; Michael R Betts; Shelly J Krebs; Bonnie M Slike; Sorachai Nitayaphan; Kathleen Rono; Sodsai Tovanabutra; Lucas Maganga; Hannah Kibuuka; Linda Jagodzinski; Sheila Peel; Morgane Rolland; Mary A Marovich; Jerome H Kim; Nelson L Michael; Merlin L Robb; Hendrik Streeck
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

Review 9.  Assessing immune aging in HIV-infected patients.

Authors:  Victor Appay; Delphine Sauce
Journal:  Virulence       Date:  2016-06-16       Impact factor: 5.882

10.  Transcriptome analysis of primary monocytes from HIV-positive patients with differential responses to antiretroviral therapy.

Authors:  Jing Qin Wu; Tara Ruth Sassé; Monica Miranda Saksena; Nitin K Saksena
Journal:  Virol J       Date:  2013-12-27       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.